Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of interleukin-5 as marker and/or inhibitor of activity of acute pancreatitis digestive enzyme

A technology for the activity of interleukin and digestive enzymes, applied in the field of medicine, can solve the problem of lack of interleukin-5

Active Publication Date: 2021-09-14
AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is currently no report on the relationship between interleukin-5 and digestive enzyme activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of interleukin-5 as marker and/or inhibitor of activity of acute pancreatitis digestive enzyme
  • Application of interleukin-5 as marker and/or inhibitor of activity of acute pancreatitis digestive enzyme
  • Application of interleukin-5 as marker and/or inhibitor of activity of acute pancreatitis digestive enzyme

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1: Construction of a mouse model of arginine acute pancreatitis

[0052] Twenty g-25g male C57BL / 6 mice (purchased from Hunan Slack Jingda Experimental Animal Co., Ltd.) were fasted overnight and intraperitoneally injected L-arginine hydrochloride 3.3g / kg three times with an interval of 1h between each injection. After the last intraperitoneal injection, the mice were sacrificed at 1h (4), 3h (4), 6h (4), 12h (3), 24h (3) and 48h (2), and their serum was taken for detection .

[0053] Such as figure 2 As shown, the amylase in the serum was at a higher level 1h-24h after the seventh intraperitoneal injection, and decreased at 48h.

[0054] Such as image 3 As shown, the level of lipase in serum gradually increased 1h-6h after the seventh intraperitoneal injection, and gradually decreased 6-48h.

[0055] Such as Figure 4 As shown, the content of interleukin-5 in the serum was at a high level 1h-24h after the seventh intraperitoneal injection, and there was ...

Embodiment 2

[0059] Example 2: Construction of mouse cerulein LPS acute pancreatitis model

[0060] Twenty-seven 20g-25g male C57BL / 6 mice were fasted overnight and injected intraperitoneally with cerulein 50μg / kg for 7 times with an interval of 1 hour. After the last injection of cerulein, LPS was injected intraperitoneally. 1h (4), 3h (4), 6h (4), 12h (4), 24h (4), 48h (4) and 72h (3) after the last injection, the mice were sacrificed , take its serum test.

[0061] Such as Figure 5 and Figure 6 As shown, amylase and lipase in serum reached the highest level 6 hours after the seventh intraperitoneal injection, and then decreased.

[0062] Such as Figure 7 As shown, interleukin-5 in serum was high within 1h-6h after the seventh intraperitoneal injection, and the level decreased thereafter.

[0063] Such as Figure 8 As shown, interleukin-2 in serum was high within 3h-6h after the seventh intraperitoneal injection, and the level decreased thereafter.

[0064] Such as Figure 9 A...

Embodiment 3

[0071] Example 3: Construction of mouse cerulein acute pancreatitis model

[0072] 20g-25g male C57BL / 6 mice were fasted overnight and divided into three groups: normal saline group (5 mice), model group (10 mice), and intervention group (10 mice). The normal saline group was injected with the same volume of normal saline, intraperitoneal injection 7 times with an interval of 1 hour between each time. The model group was intraperitoneally injected 50 μg / kg cerulein 7 times with an interval of 1 hour between each time. The intervention group was injected intraperitoneally with cerulein 50 μg / kg for 7 times with an interval of 1 hour, and interleukin-5 receptor inhibitor was injected intraperitoneally immediately after the first intraperitoneal injection. Twelve hours after the last injection, the mice in the three groups were sacrificed, and their serum was taken for detection.

[0073] Such as Figure 10 and Figure 11 As shown, the activities of amylase and lipase in the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of interleukin-5 as a marker and / or an inhibitor of the activity of an acute pancreatitis digestive enzyme, and belongs to the technical field of medicines. Studies find that the interleukin-5 can monitor the activity of the acute pancreatitis digestive enzyme and can also be used for inhibiting the activity of the acute pancreatitis digestive enzyme. Therefore, the interleukin-5 can be used as the marker of the activity of the acute pancreatitis digestive enzyme and can also be used as the inhibitor of the activity of the acute pancreatitis digestive enzyme, new application of the interleukin-5 is developed, and the interleukin-5 has positive pharmaceutical value.

Description

technical field [0001] The invention relates to the application of interleukin-5 as a marker and / or inhibitor of digestive enzyme activity in acute pancreatitis, and belongs to the technical field of medicine. Background technique [0002] Acute pancreatitis is an unpredictable and potentially fatal disease. Over the past decade, the treatment of acute pancreatitis has gradually shifted to a multidisciplinary, minimally invasive approach. Although treatment methods are improving, the mortality rate of severe pancreatitis is still relatively high, reaching 20%-40%. The reason why there is no specific treatment for acute pancreatitis is that its pathogenesis has not been fully elucidated. Current studies have shown that the pathogenesis of acute pancreatitis includes the activation of NFκB pathway and the activation of trypsin (pancreatin for short). The former can cause local and even systemic inflammatory reactions, while the latter can activate digestive enzymes such as l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/20A61P1/18A61P29/00G01N33/68
CPCA61K38/2033A61P1/18A61P29/00G01N33/6869
Inventor 肖娟张鹏程曾稳盈周袁方强强
Owner AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV